TSMC's U.S. shares declined as leveraged selling spread beyond Korea despite the chipmaker's record quarterly profit.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
AMD secured substantial data-center capacity, but the agreement failed to insulate its shares from the global semiconductor selloff.
Tesla extended its losing streak as analysts lowered targets following weaker-than-expected second-quarter earnings.
SK Hynix's earnings disappointment intensified investor scrutiny of AI spending and semiconductor growth expectations.
Elon Musk has lost $300 billion in the last six weeks.
Baird reduced its price target by $300 as data-center restrictions created new risks for Caterpillar's power-equipment growth.
P&G forecast weaker annual growth and maintained an estimated $1 billion profit hit from higher costs.
Shipment delays and limited shareholder-return detail overshadowed a sixfold operating-profit increase and strong AI-memory demand.
Forced selling and concerns about AI-chip expectations intensified Samsung's decline during a record-setting South Korean market rout.
A new Korean regulation could have unintended consequences for Micron investors.
AI Stock Rally Faces Reality Check as Earnings Beats Fall Flat
The market is worried that some sales challenges in the second quarter may not prove temporary.
Caterpillar stock sinks as Baird downgrades it to Neutral. Here’s why the firm turned bearish on CAT shares today.
Individual investors just recorded “their largest net selling of single stocks since the COVID crash,” according to Vanda Research.
Tech stocks were lower Wednesday afternoon, with the State Street Technology Select Sector SPDR ETF
The brokerage stated that growing opposition to data centre construction could weigh on demand for construction equipment and compress Caterpillar's valuation.
Heavy, unusual put option volume today in Corning Inc. (GLW) shows some investors believe GLW is cheap after generating strong free cash flow. The out-of-the-money 6-month GLW short-put play is bullish.
Though positive, mid-stage study results erased about two-thirds of the biotech's market value this week. But Christopher Kroeger sees MapLight's drug as competitive based on the "totality of data."
Teva Pharmaceutical Industries climbed above an important chart level Wednesday, after the company's bullish guidance overshadowed mixed second-quarter results. Teva earnings thinned to 2 cents a share after subtracting costs from an acquisition. The profit came in below the consensus estimate of 5 cents a share.
With an hour to go until the Federal Reserve’s big rate-cut decision, the stock market is already selling off. The Dow Jones Industrial Average was down 823 points, or 1.6%. The Nasdaq Composite dropped 1%.
Wall Street is watching Akamai Technologies closely after a blockbuster deal reshaped the company's growth story earlier this year. Morgan Stanley reaffirmed its “Overweight” rating on Akamai (AKAM) in a July 27 research note shared with me, keeping its price target at $165, roughly 48% above the ...
AXS's Q2 results reflect premium growth, but higher catastrophe losses and weaker investment income weigh on earnings.
Lemonade is facing a brutal sell-off despite posting strong sales growth in Q2.
Warren and Schiff want an SEC investigation into Trump Media's Truth API, the $100,000 paid feed launching August 1. Two precedents show how it ends.
Credit markets are quietly repricing the AI infrastructure boom, and the pain is landing hardest on a handful of heavily levered names whose borrowing costs just hit levels that historically signal serious distress.
Semiconductors are caught in a selloff UBS thinks is overblown. The bank argues that fears over "circular financing" in AI infrastructure deals misread who's actually cashing in on the buildout, and it's the chip supply chain, not the hyperscalers, footing the bill. The commentary follows...